Blog

Juan Gómez Rivas: New Study by Pieter Vynckier et al. on prostate cancer

Photo taken from Juan Gómez Rivas/X

May 26, 2024, 09:32

Juan Gómez Rivas: New Study by Pieter Vynckier et al. on prostate cancer

Juan Gómez Rivas, Associate Professor at The Complutense University of Madrid, made the following post on X:

“New Study Alert!

In Europe, prostate cancer is the leading cancer among men. A recent systematic review highlights the cost-effectiveness of PCa screening programs. Findings suggest risk-based screening followed by MRI is a promising strategy.”

Read further.
Source: Juan Gómez Rivas/X
.

Associate Professor cancer cost-effectiveness europe Juan Gómez Rivas leading cancer men MRI OncoDaily Oncology PCa screening programs Pieter Vynckier promising strategy prostate cancer risk-based screening systematic review The Complutense University of Madrid

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage